JNJ vs INCY
By Alex · Tickerpine
Johnson & Johnson vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | INCY |
|---|---|---|
| Price | $260.86 | $120.77 |
| Market cap | $628.65B | $24.48B |
| P/E ratio | 30.3 | 15.4 |
| ROE | 25.74% | 30.67% |
| Profit margin | 21.48% | 27.71% |
| Revenue growth | 6.60% | 37.70% |
| Dividend yield | 2.05% | — |
| Beta | 0.23 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs INCY in plain English
- JNJ is the bigger company — about 25.7× the market cap of INCY.
- INCY is cheaper on earnings (P/E 15.4 vs 30.3).
- INCY earns a higher return on equity (31% vs 26%).
- INCY is growing revenue faster (38% vs 7%).
- JNJ pays a dividend (2.05%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.